Laura Indolfi, PhD is the Chief Executive Officer and Co-Founder of PanTher Therapeutics. Laura combines science and business knowledge to drive PanTher’s vision. Prior to founding PanTher Therapeutics, she was a postdoctoral associate at the Harvard-MIT Institute for Medical Engineering and Science and served as an entrepreneur-in-residence at the Massachusetts General Hospital Cancer Center.
Laura’s broad professional experience and interests range from biomedical engineering to entrepreneurship and outreach initiatives to promoting science. Her scientific expertise covers multiple therapeutic areas (cardio, cancer, inflammation, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business Schools and with several consulting firms.
She was named a TED Fellow, one of 21 people chosen annually by the TED organization who are considered the most disruptive and transformative change-makers in the world. Laura has also attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing entrepreneurs, executives, and innovators in business. Laura is also one of the five women selected by Massachusetts Life Science Center and Takeda for their inaugural class in 2018 of the MassNextGen program, honoring exceptional leaders in the biotech industry.
Laura holds a PhD in Biomaterials and MS and BS degrees in Materials Science and Engineering from the University of Naples Federico II in Italy.